| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $2.1M | +9.3% |
| SG&A Expense | $2.0M | -4.2% |
| Operating Income | -$4.9M | -3.1% |
| Pre-tax Income | $4.9M | +3.7% |
| Net Income | -$4.9M | -3.7% |
| EPS (Basic) | -$0.07 | +0.0% |
| EPS (Diluted) | -$0.07 | +0.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $767K | -74.5% |
| Accounts Receivable | $81K | +47.3% |
| Current Assets | $848K | -72.3% |
| Total Assets | $999K | -69.7% |
| Current Liabilities | $473K | -28.5% |
| Total Liabilities | $634K | -9.7% |
| Stockholders' Equity | $365K | -85.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.2M | +4.2% |
| Capital Expenditures | $2K | -96.0% |
| Investing Cash Flow | -$2K | +96.6% |
| Financing Cash Flow | $1.0M | -72.4% |
| Free Cash Flow | -$3.2M | +5.6% |